1580321000168101: bemotrizinol 17 mg / 1 g + butyl methoxydibenzoylmethane 25 mg / 1 g + diethylamino hydroxybenzoyl hexyl benzoate 20 mg / 1 g + octocrylene 20 mg / 1 g + octyl methoxycinnamate 60 mg / 1 g + titanium dioxide 42 mg / 1 g lotion, 500 mL (medicinal product pack)

• Australian concept\Australian product\medicinal product pack\bemotrizinol 1.7% + butyl methoxydibenzoylmethane 2.5% + octocrylene 2% + octyl methoxycinnamate 6% + diethylamino hydroxybenzoyl hexyl benzoate 2% + titanium dioxide 4.2% lotion, 500 mL

Status: current, Defined. Date: 30-Nov 2021. Module: Australian Medicines Terminology module

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
4639331000168119	bemotrizinol 17 mg / 1 g + butyl methoxydibenzoylmethane 25 mg / 1 g + diethylamino hydroxybenzoyl hexyl benzoate 20 mg / 1 g + octocrylene 20 mg / 1 g + octyl methoxycinnamate 60 mg / 1 g + titanium dioxide 42 mg / 1 g lotion, 500 mL (medicinal product pack)	en	Fully specified name	Active	Case sensitive	Australian Medicines Terminology module
4639341000168111	bemotrizinol 1.7% + butyl methoxydibenzoylmethane 2.5% + octocrylene 2% + octyl methoxycinnamate 6% + diethylamino hydroxybenzoyl hexyl benzoate 2% + titanium dioxide 4.2% lotion, 500 mL	en	Synonym	Active	Case sensitive	Australian Medicines Terminology module

Expanded Value Set

Reference Sets

List of Excluded Medicinal Items reference set

Medicinal product pack reference set

Back to Start